Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Browse (e)

a b c d e f g h i j k l m n o p q r s t u v w x y z (0-9)

Econazole Topical

Eculizumab Injection

Edaravone Injection

Edaravone Oral

Edoxaban

Efavirenz

Efavirenz, Emtricitabine, and Tenofovir

Efavirenz, Lamivudine, and Tenofovir

Efbemalenograstim alfa-vuxw Injection

Efgartigimod alfa and Hyaluronidase-qvfc Injection

Efgartigimod alfa-fcab Injection

Efinaconazole Topical

Eflornithine

Eflornithine

Elacestrant

Eladocagene exuparvovec-tneq Injection

Elafibranor

Elagolix

Elagolix, Estradiol, and Norethindrone

Elbasvir and Grazoprevir

Eletriptan

Elexacaftor, Tezacaftor, and Ivacaftor

Eliglustat

Elivaldogene autotemcel Injection

Elotuzumab Injection

Elranatamab-bcmm

Eltrombopag

Eluxadoline

Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir

Emapalumab-lzsg Injection

Emicizumab-kxwh Injection

Empagliflozin

Emtricitabine

Emtricitabine and Tenofovir

Emtricitabine, Rilpivirine, and Tenofovir

Enalapril

Enalapril and Hydrochlorothiazide

Enasidenib

Encorafenib

Enfortumab vedotin-ejfv Injection

Enfuvirtide Injection

Enoxaparin Injection

Ensartinib

Ensifentrine Oral Inhalation

Entacapone

Entecavir

Entrectinib

Enzalutamide

Epcoritamab-bysp Injection

Epinastine Ophthalmic

Epinephrine Injection

Epinephrine Nasal Spray

Epinephrine Oral Inhalation

Epirubicin

Eplerenone

Eplontersen injection

Epoetin Alfa, Injection

Epoprostenol

Eprosartan

Eptinezumab-jjmr Injection

Eravacycline Injection

Erdafitinib

Erenumab-aooe Injection

Ergocalciferol

Ergoloid Mesylates

Ergotamine and Caffeine

Eribulin Injection

Erlotinib

Ertapenem Injection

Ertugliflozin

Erythromycin

Erythromycin and Benzoyl Peroxide Topical

Erythromycin and Sulfisoxazole

Erythromycin Ophthalmic

Escitalopram

Esketamine Nasal Spray

Eslicarbazepine

Esomeprazole

Esomeprazole Injection

Estazolam

Estradiol Topical

Estradiol Transdermal Patch

Estramustine

Estrogen

Estrogen and Bazedoxifene

Estrogen and Progestin (Hormone Replacement Therapy)

Estrogen and Progestin Transdermal Patch (Hormone Replacement Therapy)

Estrogen Injection

Estrogen Vaginal

Eszopiclone

Etanercept Injection

Etelcalcetide Injection

Ethacrynic Acid

Ethambutol

Ethosuximide

Etidronate

Etodolac

Etoposide

Etoposide Injection

Etranacogene dezaparvovec-drlb Injection

Etrasimod

Etravirine

Everolimus

Evinacumab-dgnb Injection

Evolocumab Injection

Exagamglogene autotemcel

Exemestane

Exenatide Injection

Ezetimibe

Ezogabine

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

5115 Fannin, Suite 801
Houston, TX 77004

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary